Kratom and Future Treatment for the Opioid Addiction and Chronic Pain: Periculo Beneficium?

Ismaliza Ismail, Suzaily Wahab, Hatta Sidi, Srijit Das, Loo Jiann Lin, Rosdinom Razali

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Kratom (Mitragyna speciosa), a naturally existing plant found in South-East Asia, is traditionally used as a herb to help elevate a person's energy and also to treat numerous medical ailments. Other than the analgesic property, kratom has been used as an agent to overcome opioid withdrawal as it contains natural alkaloids, i.e. mitragynine, 7-hydroxymitragynine, and MGM-9, which has agonist affinity on the opioid receptors, including mu (µ) and kappa (κ). The role of neural reward pathways linked to µ-opioid receptors and both dopaminergic and gamma-Aminobutyric acid (GABA)-ergic interneurons that express µ-opioid receptors were deliberated. However, kratom has been reported to be abused together with other illicit substances with high risk of potential addiction. There are also anecdotes of adverse effects and toxicity of kratom, i.e. tremor, fatigue, seizure, and death. Different countries have distinctive regulation and policy on the plantation and use of this plant when most of the countries banned the use of it because of its addiction problems and side effects. The aim of this review is to highlight on the potential use of kratom, unique 'herbs" as a substitution therapy for chronic pain and opioid addiction, based on the neurobiological perspective of pain and the underlying mechanism of actions of drug addiction.

Original languageEnglish
Pages (from-to)166-172
Number of pages7
JournalCurrent Drug Targets
Volume20
Issue number2
DOIs
Publication statusPublished - 1 Jan 2019

Fingerprint

Opioid Receptors
Chronic Pain
Opioid Analgesics
Mitragyna
Anecdotes
Neural Pathways
kappa Opioid Receptor
Far East
mu Opioid Receptor
Tremor
Interneurons
Reward
Alkaloids
gamma-Aminobutyric Acid
Substance-Related Disorders
Fatigue
Analgesics
Seizures
Pain
Toxicity

Keywords

  • 7-hydroxymitragynine
  • Ketum
  • kratom
  • mitragyna speciose
  • mitragynine
  • opioid receptors.

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology
  • Drug Discovery
  • Clinical Biochemistry

Cite this

Kratom and Future Treatment for the Opioid Addiction and Chronic Pain : Periculo Beneficium? / Ismail, Ismaliza; Wahab, Suzaily; Sidi, Hatta; Das, Srijit; Lin, Loo Jiann; Razali, Rosdinom.

In: Current Drug Targets, Vol. 20, No. 2, 01.01.2019, p. 166-172.

Research output: Contribution to journalArticle

@article{ee8e8b00246843d58d6c07206c0a0bb5,
title = "Kratom and Future Treatment for the Opioid Addiction and Chronic Pain: Periculo Beneficium?",
abstract = "Kratom (Mitragyna speciosa), a naturally existing plant found in South-East Asia, is traditionally used as a herb to help elevate a person's energy and also to treat numerous medical ailments. Other than the analgesic property, kratom has been used as an agent to overcome opioid withdrawal as it contains natural alkaloids, i.e. mitragynine, 7-hydroxymitragynine, and MGM-9, which has agonist affinity on the opioid receptors, including mu (µ) and kappa (κ). The role of neural reward pathways linked to µ-opioid receptors and both dopaminergic and gamma-Aminobutyric acid (GABA)-ergic interneurons that express µ-opioid receptors were deliberated. However, kratom has been reported to be abused together with other illicit substances with high risk of potential addiction. There are also anecdotes of adverse effects and toxicity of kratom, i.e. tremor, fatigue, seizure, and death. Different countries have distinctive regulation and policy on the plantation and use of this plant when most of the countries banned the use of it because of its addiction problems and side effects. The aim of this review is to highlight on the potential use of kratom, unique 'herbs{"} as a substitution therapy for chronic pain and opioid addiction, based on the neurobiological perspective of pain and the underlying mechanism of actions of drug addiction.",
keywords = "7-hydroxymitragynine, Ketum, kratom, mitragyna speciose, mitragynine, opioid receptors.",
author = "Ismaliza Ismail and Suzaily Wahab and Hatta Sidi and Srijit Das and Lin, {Loo Jiann} and Rosdinom Razali",
year = "2019",
month = "1",
day = "1",
doi = "10.2174/1389450118666170425154120",
language = "English",
volume = "20",
pages = "166--172",
journal = "Current Drug Targets",
issn = "1389-4501",
publisher = "Bentham Science Publishers B.V.",
number = "2",

}

TY - JOUR

T1 - Kratom and Future Treatment for the Opioid Addiction and Chronic Pain

T2 - Periculo Beneficium?

AU - Ismail, Ismaliza

AU - Wahab, Suzaily

AU - Sidi, Hatta

AU - Das, Srijit

AU - Lin, Loo Jiann

AU - Razali, Rosdinom

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Kratom (Mitragyna speciosa), a naturally existing plant found in South-East Asia, is traditionally used as a herb to help elevate a person's energy and also to treat numerous medical ailments. Other than the analgesic property, kratom has been used as an agent to overcome opioid withdrawal as it contains natural alkaloids, i.e. mitragynine, 7-hydroxymitragynine, and MGM-9, which has agonist affinity on the opioid receptors, including mu (µ) and kappa (κ). The role of neural reward pathways linked to µ-opioid receptors and both dopaminergic and gamma-Aminobutyric acid (GABA)-ergic interneurons that express µ-opioid receptors were deliberated. However, kratom has been reported to be abused together with other illicit substances with high risk of potential addiction. There are also anecdotes of adverse effects and toxicity of kratom, i.e. tremor, fatigue, seizure, and death. Different countries have distinctive regulation and policy on the plantation and use of this plant when most of the countries banned the use of it because of its addiction problems and side effects. The aim of this review is to highlight on the potential use of kratom, unique 'herbs" as a substitution therapy for chronic pain and opioid addiction, based on the neurobiological perspective of pain and the underlying mechanism of actions of drug addiction.

AB - Kratom (Mitragyna speciosa), a naturally existing plant found in South-East Asia, is traditionally used as a herb to help elevate a person's energy and also to treat numerous medical ailments. Other than the analgesic property, kratom has been used as an agent to overcome opioid withdrawal as it contains natural alkaloids, i.e. mitragynine, 7-hydroxymitragynine, and MGM-9, which has agonist affinity on the opioid receptors, including mu (µ) and kappa (κ). The role of neural reward pathways linked to µ-opioid receptors and both dopaminergic and gamma-Aminobutyric acid (GABA)-ergic interneurons that express µ-opioid receptors were deliberated. However, kratom has been reported to be abused together with other illicit substances with high risk of potential addiction. There are also anecdotes of adverse effects and toxicity of kratom, i.e. tremor, fatigue, seizure, and death. Different countries have distinctive regulation and policy on the plantation and use of this plant when most of the countries banned the use of it because of its addiction problems and side effects. The aim of this review is to highlight on the potential use of kratom, unique 'herbs" as a substitution therapy for chronic pain and opioid addiction, based on the neurobiological perspective of pain and the underlying mechanism of actions of drug addiction.

KW - 7-hydroxymitragynine

KW - Ketum

KW - kratom

KW - mitragyna speciose

KW - mitragynine

KW - opioid receptors.

UR - http://www.scopus.com/inward/record.url?scp=85053194239&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053194239&partnerID=8YFLogxK

U2 - 10.2174/1389450118666170425154120

DO - 10.2174/1389450118666170425154120

M3 - Article

C2 - 28443503

AN - SCOPUS:85053194239

VL - 20

SP - 166

EP - 172

JO - Current Drug Targets

JF - Current Drug Targets

SN - 1389-4501

IS - 2

ER -